Penguin AI says its November 2026 survey of 500 U.S. adults found that 62% of respondents who faced a prior‑authorization delay, denial, or medication restriction stopped pursuing care because fighting the insurer wasn’t worth it. Overall, 48% of all respondents said they had given up on care. Only 44% appealed a decision, and of those, 47% won. The survey also shows that 87% would back AI tools that speed up approvals, but most want a human to oversee the final decision.
Why it matters
Patients may skip needed treatment, so insurers and providers could reduce drop‑offs by using AI‑assisted prior‑auth processes with human oversight.
